Unclassified

Role of Citicoline in Neonates with Hypoxic-Ischaemic Encephalopathy. | ClinicLens

To evaluate the short-term neurological outcomes in neonates with moderate-to-severe hypoxic-ischaemic encephalopathy (HIE) treated with citicoline. A randomised controlled trial. Place and Duration of the Study: Department of Paediatrics, Pak Emirates Military Hospital, Rawalpin

Medical Literature · Updated

← Back to articles
This standalone article is served from the ClinicLens content archive.

If the embedded page does not load in your browser, open it directly.